129 related articles for article (PubMed ID: 17494054)
41. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
[TBL] [Abstract][Full Text] [Related]
42. Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novo acute myeloid leukemia in Israeli ethnic groups.
Müller P; Asher N; Heled M; Cohen SB; Risch A; Rund D
Leuk Res; 2008 Jun; 32(6):919-29. PubMed ID: 18207572
[TBL] [Abstract][Full Text] [Related]
43. Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin.
Rajendra R; Gounder MK; Saleem A; Schellens JH; Ross DD; Bates SE; Sinko P; Rubin EH
Cancer Res; 2003 Jun; 63(12):3228-33. PubMed ID: 12810652
[TBL] [Abstract][Full Text] [Related]
44. CXC Chemokine Receptor Type 5 Gene Polymorphisms in a Cohort of Egyptian Patients with Diffuse Large B-Cell Lymphoma.
Makhlouf MM; Radwan ER; Khorshed OM; Fathi LM; Elmasry MM
Pathobiology; 2021; 88(3):211-217. PubMed ID: 33378752
[TBL] [Abstract][Full Text] [Related]
45. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
[TBL] [Abstract][Full Text] [Related]
46. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
47. Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma.
Espinosa I; Briones J; Bordes R; Brunet S; Martino R; Sureda A; Prat J; Sierra J
Ann Hematol; 2006 Sep; 85(9):597-603. PubMed ID: 16830142
[TBL] [Abstract][Full Text] [Related]
48. Impact of breast cancer resistance protein on cancer treatment outcomes.
Ross DD; Nakanishi T
Methods Mol Biol; 2010; 596():251-90. PubMed ID: 19949928
[TBL] [Abstract][Full Text] [Related]
49. The contribution of the ABCG2 C421A polymorphism to cancer susceptibility: a meta-analysis of the current literature.
Chen P; Zhao L; Zou P; Xu H; Lu A; Zhao P
BMC Cancer; 2012 Sep; 12():383. PubMed ID: 22937733
[TBL] [Abstract][Full Text] [Related]
50. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients.
Lee SH; Kim H; Hwang JH; Lee HS; Cho JY; Yoon YS; Han HS
Pathol Int; 2012 Mar; 62(3):167-75. PubMed ID: 22360504
[TBL] [Abstract][Full Text] [Related]
51. Polymorphisms in cytokine genes as prognostic markers in diffuse large B cell lymphoma patients treated with (R)-CHOP.
Liu D; Wang Y; Dong M; Guan S; Wang Y; Sun H; Wu N; Li S; Bai J; Chen F; Sun D; Jin Y
Ann Hematol; 2017 Feb; 96(2):227-235. PubMed ID: 27822610
[TBL] [Abstract][Full Text] [Related]
52. Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy.
Erdilyi DJ; Kámory E; Csókay B; Andrikovics H; Tordai A; Kiss C; Filni-Semsei A; Janszky I; Zalka A; Fekete G; Falus A; Kovács GT; Szalai C
Pharmacogenomics J; 2008 Oct; 8(5):321-7. PubMed ID: 17938643
[TBL] [Abstract][Full Text] [Related]
53. Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology.
Hutson JR; Koren G; Matthews SG
Placenta; 2010 May; 31(5):351-7. PubMed ID: 20347140
[TBL] [Abstract][Full Text] [Related]
54. Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma.
Andreadis C; Gimotty PA; Wahl P; Hammond R; Houldsworth J; Schuster SJ; Rebbeck TR
Blood; 2007 Apr; 109(8):3409-16. PubMed ID: 17179223
[TBL] [Abstract][Full Text] [Related]
55. Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.
Noguchi K; Katayama K; Mitsuhashi J; Sugimoto Y
Adv Drug Deliv Rev; 2009 Jan; 61(1):26-33. PubMed ID: 19111841
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of Alteration in Hepatic and Intestinal BCRP Function In Vivo from ABCG2 c.421C>A Polymorphism Based on PBPK Analysis of Rosuvastatin.
Futatsugi A; Toshimoto K; Yoshikado T; Sugiyama Y; Kato Y
Drug Metab Dispos; 2018 May; 46(5):749-757. PubMed ID: 29440178
[TBL] [Abstract][Full Text] [Related]
57. Genetic polymorphism and transcriptional regulation of
Zhao H; Kan Y; Wang X; Chen L; Ge P; Qian Z
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31366566
[TBL] [Abstract][Full Text] [Related]
58. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
Kovalev AA; Tsvetaeva DA; Grudinskaja TV
Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
[TBL] [Abstract][Full Text] [Related]
59. [Association of gene polymorphisms in the DNA repair gene XPD with risk of non-Hodgkin's lymphoma].
Song B; Zhu JY; Liu J; Wang ZH; Shi Y; Lü LY; Zheng Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):97-100. PubMed ID: 18315909
[TBL] [Abstract][Full Text] [Related]
60. Methylenetetrahydrofolate reductase gene polymorphisms (677C > T and 1298A > C) in Egyptian patients with non-Hodgkin lymphoma.
Nasr AS; Sami RM; Ibrahim NY
J Cancer Res Ther; 2012; 8(3):355-60. PubMed ID: 23174714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
